HOPE has announced plans to assemble a best-in-class global network of interventional psychiatry clinics combining ketamine treatment with transcranial magnetic stimulation, and digital therapeutics ...

HOPE Therapeutics™, Inc. ("HOPE"), a medical and technology driven company, and a wholly-owned subsidiary of NRx ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

Before she was elected as the MLA for Langley-Willowbrook last fall, Jody Toor misrepresented her medical credentials to get a job as chief medical officer for a local company that ...

FDA approves esketamine nasal spray as a standalone treatment for adults with treatment-resistant depression, offering rapid ...

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...

Many more Americans are turning to ketamine for kicks, a new study reports.

In 2019, the U.S. Food and Drug Administration (FDA) approved the use of a nasal spray ketamine derivative called esketamine (Spravato) to treat depression in adults, according to the National ...

Please purchase a subscription to read our premium content. If you have a subscription, please log in or sign up for an account on our website to continue.

Recreational ketamine use has local researchers sounding the alarm. Dr. Philip Botkiss is the medical director of the West Coast Ketamine Center. He says he's seen a good response from patients ...

Celebrities like Matthew Perry, Chrissy Teigen and others have been open about using ketamine infusion therapy to help treat mental health conditions. According to the United States Drug ...